Second-Order Calibration of Excitation—Emission Matrix Fluorescence Spectra for the Determination of N-Phenylanthranilic Acid Derivatives

A spectrofluorimetric method has been developed for the quantitative determination of mefenamic, flufenamic, and meclofenamic acids in urine samples. The method is based on second-order data multivariate calibration (unfolded partial least squares (unfolded-PLS), multi-way PLS (N-PLS), parallel factor analysis (PARAFAC), self-weighted alternating trilinear decomposition (SWATLD), and bilinear least squares (BLLS)). The analytes were extracted from the urine samples in chloroform prior to the determination. The chloroform extraction was optimized for each analyte, studying the agitation time and the extraction pH, and the optimum values were 10 minutes and pH 3.5, respectively. The concentration ranges in chloroform solution of each of the analytes, used to construct the calibration matrix, were selected in the ranges from 0.15 to 0.8 μg mL−1 for flufenamic and meclofenamic acids and from 0.25 to 3.0 μg mL−1 for mefenamic acid. The combination of chloroform extraction and second-order calibration methods, using the excitation–emission matrices (EEMs) of the three analytes as analytical signals, allowed their simultaneous determination in human urine samples, in the range of approximately 80 mg L−1 to 250 mg L−1, with satisfactory results for all the assayed methods. Improved results over unfolded-PLS and N-PLS were found with PARAFAC, SWATLD, and BLLS, methods that exploit the second-order advantage.

[1]  S. Schulman,et al.  Native fluorescence of analgesics derived from N-phenylanthranilic acid. , 1973, Talanta.

[2]  L. Hackett,et al.  Gas-liquid chromatographic determination of mefenamic acid in human serum. , 1978, Journal of chromatography.

[3]  P. Salvà,et al.  Quantitative determination of flufenamic acid in rat plasma and uterus by gas chromatography. , 1980, Journal of chromatography.

[4]  H. Daabees,et al.  Some spectrophotometric methods for determination of certain antipyretic and antirheumatic drugs. , 1985, Talanta.

[5]  Bruce R. Kowalski,et al.  Generalized rank annihilation factor analysis , 1986 .

[6]  Bruce R. Kowalski,et al.  Tensorial calibration: II. Second‐order calibration , 1988 .

[7]  E. V. Thomas,et al.  Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information , 1988 .

[8]  S. Wold,et al.  Residual bilinearization. Part 1: Theory and algorithms , 1990 .

[9]  B. Kowalski,et al.  Theory of analytical chemistry , 1994 .

[10]  M. I. Albero,et al.  Flow-injection spectrofluorimetric determination of flufenamic and mefenamic acid in pharmaceuticals. , 1995, Journal of pharmaceutical and biomedical analysis.

[11]  R. Bro.  Multiway calibration. Multilinear PLS , 1996 .

[12]  R. Bro.  PARAFAC. Tutorial and applications , 1997 .

[13]  V. Tomás,et al.  Analysis of binary mixtures of flufenamic, meclofenamic and mefenamic acids by derivative synchronous fluorescence spectrometry. , 1998, Talanta.

[14]  Rolf Sundberg,et al.  Second-order calibration: bilinear least squares regression and a simple alternative , 1998 .

[15]  T. Pérez-Ruíz,et al.  Determination of flufenamic, meclofenamic and mefenamic acids by capillary electrophoresis using beta-cyclodextrin. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[16]  M. A. Herrador,et al.  Intra-laboratory testing of method accuracy from recovery assays. , 1999, Talanta.

[17]  Yang Li,et al.  A novel trilinear decomposition algorithm for second-order linear calibration , 2000 .

[18]  R Todeschini,et al.  Resolution of mixtures of three nonsteroidal anti-inflammatory drugs by fluorescence using partial least squares multivariate calibration with previous wavelength selection by Kohonen artificial neural networks. , 2000, Talanta.

[19]  K. Booksh,et al.  Mitigation of Rayleigh and Raman spectral interferences in multiway calibration of excitation-emission matrix fluorescence spectra. , 2000, Analytical chemistry.

[20]  Y. Z. Cao,et al.  A PARAFAC algorithm using penalty diagonalization error (PDE) for three-way data array resolution. , 2000, The Analyst.

[21]  R. Tauler,et al.  Determination of triphenyltin in sea-water by excitation–emission matrix fluorescence and multivariate curve resolution , 2000 .

[22]  Romà Tauler,et al.  Strategies for solving matrix effects in the analysis of triphenyltin in sea-water samples by three-way multivariate curve resolution , 2000 .

[23]  A. Al-Warthan,et al.  Determination of flufenamic acid and mefenamic acid in pharmaceutical preparations and biological fluids using flow injection analysis with tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection , 2000 .

[24]  L. Moberg,et al.  Spectrofluorimetric determination of chlorophylls and pheopigments using parallel factor analysis. , 2001, Talanta.

[25]  R. Yu,et al.  Spectrofluorometric resolution of closely overlapping drug mixtures using chemometrics methods. , 2002, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[26]  Rolf Sundberg,et al.  Precision of prediction in second‐order calibration, with focus on bilinear regression methods , 2002 .

[27]  G. M. Escandar,et al.  First- and second-order multivariate calibration applied to biological samples: determination of anti-inflammatories in serum and urine , 2002, Analytical and bioanalytical chemistry.

[28]  F. S. Costa,et al.  Detection of verapamil drug by fluorescence and trilinear decomposition techniques , 2002 .

[29]  Alejandro C Olivieri,et al.  Interference-free analysis using three-way fluorescence data and the parallel factor model. Determination of fluoroquinolone antibiotics in human serum. , 2003, Analytical chemistry.

[30]  G. M. Escandar,et al.  Two different strategies for the fluorimetric determination of piroxicam in serum. , 2003, Talanta.

[31]  R. Poppi,et al.  Determination of doxorubicin in human plasma by excitation-emission matrix fluorescence and multi-way analysis , 2003 .

[32]  R. Bro,et al.  Practical aspects of PARAFAC modeling of fluorescence excitation‐emission data , 2003 .

[33]  R. Bro,et al.  A new efficient method for determining the number of components in PARAFAC models , 2003 .

[34]  G. M. Escandar,et al.  Spectrofluorimetric study of the beta-cyclodextrin-ibuprofen complex and determination of ibuprofen in pharmaceutical preparations and serum. , 2003, Talanta.

[35]  F. X. Rius,et al.  Determination of carbendazim, fuberidazole and thiabendazole by three-dimensional excitation–emission matrix fluorescence and parallel factor analysis , 2003 .

[36]  A. Espinosa-Mansilla,et al.  Partial least squares multicomponent fluorimetric determination of fluoroquinolones in human urine samples. , 2004, Talanta.

[37]  G. M. Escandar,et al.  Determination of carbamazepine in serum and pharmaceutical preparations using immobilization on a nylon support and fluorescence detection , 2004 .

[38]  A. Olivieri,et al.  A test field for the second-order advantage in bilinear least-squares and parallel factor analyses: fluorescence determination of ciprofloxacin in human urine. , 2004, Analytical chemistry.

[39]  A. Muñoz de la Peña,et al.  Strategies for solving matrix effects in the analysis of sulfathiazole in honey samples using three-way photochemically induced fluorescence data. , 2005, Talanta.